Skip to main content

Table 2 Results of the final path analysis model

From: Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach

Regression

Estimate

S.E.

C.R.

Standardized

P

Uric acid

BMI

.079

.006

12.631

0.273

p < 0.001

Uric acid

Packyears

.052

.013

4.058

0.088

p < 0.001

Uric acid

Age

.019

.004

4.903

0.105

p < 0.001

CV comorbidity

Uric acid

.054

.015

3.674

0.083

p < 0.001

CV comorbidity

Age

.024

.003

9.235

0.201

p < 0.001

CV comorbidity

BMI

.033

.004

7.722

0.173

p < 0.001

FEV1

Age

.306

.051

6.009

0.137

p < 0.001

FEV1

Uric acid

−0.790

.284

−2.781

−0.065

0.005

FEV1

BMI

.565

.083

6.813

0.160

p < 0.001

FEV1

CV comorbidity

−1.294

.437

−2.963

−0.069

0.003

Exacerbations

FEV1

−.006

.001

−10.937

−0.240

p < 0.001

Exacerbations

CV comorbidity

.033

.011

3.067

0.067

0.002

6-MWD

Uric acid

−6.090

1.376

−4.425

−0.087

p < 0.001

6-MWD

FEV1

2.573

.113

22.856

0.448

p < 0.001

6-MWD

Age

−3.025

.249

−12.168

−0.236

p < 0.001

6-MWD

BMI

−3.816

.406

−9.402

−0.187

p < 0.001

6-MWD

Exacerbations

−22.530

4.276

−5.268

−0.102

p < 0.001

6-MWD

CV comorbidity

−7.578

2.120

−3.575

−0.070

p < 0.001

Covariances

  

Estimate

S.E.

C.R.

Standardized

P

Age

Packyears

1.152

.475

2.428

0.055

p < 0.015

BMI

Packyears

1.539

.302

5.102

0.116

p < 0.001

  1. The upper panel refers to the directed arrows (regression terms) depicted in Figs. 2 and 3, whereby the left part lists the arrows shown in these figures. The right part shows the results of the corresponding statistical tests. The first column of the right part shows the non-standardized estimate of the respective regression coefficient, the second column the standard error (S.E.) of this coefficient, the third column the ratio of these two values (critical ratio, C.R.) which is used for significance testing. The forth column shows the standardized estimates of the regression coefficients shown in the first column. The last column shows the significance level based on the generalized least squares (GLS) procedure of AMOS. In an analogous manner the lower panel shows the covariances (bidirectional arrows in Figs 2 and 3) between risk factors, as well as the respective standard errors, critical ratios, correlation coefficients and significance levels